Skip to main content
Premium Trial:

Request an Annual Quote

Protogene, UHN of Toronto Enter Microarray Collaboration

NEW YORK, Feb 6 – Protogene of Menlo Park, Calif., said Tuesday it had entered a collaborative agreement with the University Health Network of Toronto to evaluate its customizable oligonucleotide DNA microarrays.

“This relationship enables us to evaluate Protogene’s high quality customized arrays,” Bob McArthur, director of technology transfer and research business development at the network, said in a statement. “In the future, broader access to Protogene’s microarrays may further expand the collection of tools that we can offer to our customers."

Financial terms of the deal were not disclosed.

The University Health Network, a network of teaching hospitals with about 1,500 biomedical researchers, currently manufactures cDNA and oligonucleotide microarrays at its microarray center and sells them to researchers around the world.

Protogene, a privately held company with 90 employees, makes custom oligonucleotide DNA microarrays using a patented surface tension array technology, in situ synthesis of oligonucleotides, and high-speed inkjet printing.

Recently, Protogene announced that it would co-market its microarrays with Silicon Genetics’ GeneSpring expression analysis software. The company has also signed a deal with Sequenom to work together to combine their technologies into a silicon-based diagnostic chip.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.